Works matching AU Butterton, Joan


Results: 39
    1
    2
    3

    Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct‐Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse‐Transcriptase Inhibitor Tenofovir Disoproxil Fumarate.

    Published in:
    Clinical Pharmacology in Drug Development, 2019, v. 8, n. 7, p. 962, doi. 10.1002/cpdd.701
    By:
    • Feng, Hwa‐Ping;
    • Guo, Zifang;
    • Caro, Luzelena;
    • Talaty, Jennifer E.;
    • Mangin, Eric;
    • Panebianco, Deborah;
    • Fandozzi, Christine;
    • Zhu, Yali;
    • Marshall, William;
    • Huang, Xiaobi;
    • Hanley, William D.;
    • Jumes, Patricia;
    • Valesky, Robert;
    • Martinho, Monika;
    • Butterton, Joan R.;
    • Iwamoto, Marian;
    • Yeh, Wendy W.
    Publication type:
    Article
    4
    5
    6
    7

    Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).

    Published in:
    Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4539, doi. 10.1093/cid/ciaa803
    By:
    • Titov, Ivan;
    • Wunderink, Richard G;
    • Roquilly, Antoine;
    • Gonzalez, Daniel Rodríguez;
    • David-Wang, Aileen;
    • Boucher, Helen W;
    • Kaye, Keith S;
    • Losada, Maria C;
    • Du, Jiejun;
    • Tipping, Robert;
    • Rizk, Matthew L;
    • Patel, Munjal;
    • Brown, Michelle L;
    • Young, Katherine;
    • Kartsonis, Nicholas A;
    • Butterton, Joan R;
    • Paschke, Amanda;
    • Chen, Luke F
    Publication type:
    Article
    8

    Reply to Chao and Lai.

    Published in:
    Clinical Infectious Diseases, 2021, v. 73, n. 8, p. 1552, doi. 10.1093/cid/ciab391
    By:
    • Wunderink, Richard G;
    • Roquilly, Antoine;
    • Croce, Martin;
    • Gonzalez, Daniel Rodriguez;
    • Fujimi, Satoshi;
    • Butterton, Joan R;
    • Broyde, Natasha;
    • Popejoy, Myra W;
    • Kim, Jason Y;
    • Anda, Carisa De
    Publication type:
    Article
    9
    10

    Reply to Sfeir.

    Published in:
    2021
    By:
    • Motsch, Johann;
    • Young, Katherine;
    • Brown, Michelle L;
    • Butterton, Joan R;
    • Paschke, Amanda
    Publication type:
    Letter to the Editor
    11

    RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections.

    Published in:
    Clinical Infectious Diseases, 2020, v. 70, n. 9, p. 1799, doi. 10.1093/cid/ciz530
    By:
    • Motsch, Johann;
    • Oliveira, Cláudia Murta de;
    • Stus, Viktor;
    • Köksal, Iftihar;
    • Lyulko, Olexiy;
    • Boucher, Helen W;
    • Kaye, Keith S;
    • File, Thomas M;
    • Brown, Michelle L;
    • Khan, Ireen;
    • Du, Jiejun;
    • Joeng, Hee-Koung;
    • Tipping, Robert W;
    • Aggrey, Angela;
    • Young, Katherine;
    • Kartsonis, Nicholas A;
    • Butterton, Joan R;
    • Paschke, Amanda
    Publication type:
    Article
    12
    13

    A novel murine infection model for Shiga toxin-producing Escherichia coli.

    Published in:
    Journal of Clinical Investigation, 2012, v. 122, n. 11, p. 4012, doi. 10.1172/JCI62746
    By:
    • Mallick, Emily M.;
    • McBee, Megan E.;
    • Vanguri, Vijay K.;
    • Melton-Celsa, Angela R.;
    • Schlieper, Katherine;
    • Karalius, Brad J.;
    • O'Brien, Alison D.;
    • Butterton, Joan R.;
    • Leong, John M.;
    • Schauer, David B.
    Publication type:
    Article
    14

    Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin.

    Published in:
    British Journal of Clinical Pharmacology, 2020, v. 86, n. 5, p. 944, doi. 10.1111/bcp.14204
    By:
    • Bhagunde, Pratik;
    • Colon‐Gonzalez, Francheska;
    • Liu, Yang;
    • Wu, Jin;
    • Xu, Shiyao Sherrie;
    • Garrett, Graigory;
    • Jumes, Patricia;
    • Lasseter, Kenneth;
    • Marbury, Thomas;
    • Rizk, Matthew L.;
    • Lala, Mallika;
    • Rhee, Elizabeth G.;
    • Butterton, Joan R.;
    • Boundy, Keith
    Publication type:
    Article
    15
    16

    No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel.

    Published in:
    European Journal of Clinical Pharmacology, 2017, v. 73, n. 5, p. 593, doi. 10.1007/s00228-017-2216-4
    By:
    • Marshall, William;
    • Feng, Hwa-Ping;
    • Caro, Luzelena;
    • Talaty, Jennifer;
    • Guo, Zifang;
    • Huang, Xiaobi;
    • Panebianco, Deborah;
    • Ma, Joanne;
    • Mangin, Eric;
    • O'Reilly, Terry;
    • Butterton, Joan;
    • Yeh, Wendy
    Publication type:
    Article
    17

    Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infection.

    Published in:
    Journal of Viral Hepatitis, 2019, v. 26, n. 6, p. 675, doi. 10.1111/jvh.13079
    By:
    • Lawitz, Eric;
    • Poordad, Fred;
    • Anderson, Leah J.;
    • Vesay, Michelle;
    • Kelly, Michelle M.;
    • Liu, Hong;
    • Gao, Wei;
    • Fernsler, Doreen;
    • Asante‐Appiah, Ernest;
    • Robertson, Michael N.;
    • Hanna, George J.;
    • Barr, Eliav;
    • Butterton, Joan;
    • Kowdley, Kris V.;
    • Hassanein, Tarek;
    • Sahota, Amandeep;
    • Gordon, Stuart C.;
    • Yeh, Wendy W.
    Publication type:
    Article
    18
    19
    20
    21
    22

    No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy.

    Published in:
    CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 562, doi. 10.1111/cts.12565
    By:
    • Feng, Hwa‐Ping;
    • Guo, Zifang;
    • Caro, Luzelena;
    • Marshall, William L.;
    • Liu, Fang;
    • Panebianco, Deborah;
    • Vaddady, Pavan;
    • Barbour, April;
    • Reitmann, Christina;
    • Jumes, Patricia;
    • Gilmartin, Jocelyn;
    • Wolford, Dennis;
    • Valesky, Robert;
    • Martinho, Monika;
    • Butterton, Joan R.;
    • Iwamoto, Marian;
    • Fraser, Iain;
    • Webster, Lynn;
    • Yeh, Wendy W.
    Publication type:
    Article
    23

    No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy.

    Published in:
    CTS: Clinical & Translational Science, 2018, v. 11, n. 6, p. 553, doi. 10.1111/cts.12564
    By:
    • Feng, Hwa‐Ping;
    • Guo, Zifang;
    • Caro, Luzelena;
    • Marshall, William L.;
    • Liu, Fang;
    • Panebianco, Deborah;
    • Vaddady, Pavan;
    • Reitmann, Christina;
    • Jumes, Patricia;
    • Wolford, Dennis;
    • Fraser, Iain;
    • Valesky, Robert;
    • Martinho, Monika;
    • Butterton, Joan R.;
    • Iwamoto, Marian;
    • Webster, Lynn;
    • Yeh, Wendy W.
    Publication type:
    Article
    24

    Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study.

    Published in:
    Open Forum Infectious Diseases, 2020, v. 7, n. 3, p. N.PAG, doi. 10.1093/ofid/ofaa054
    By:
    • Brown, Michelle L;
    • Motsch, Johann;
    • Kaye, Keith S;
    • File, Thomas M;
    • Boucher, Helen W;
    • Vendetti, Neika;
    • Aggrey, Angela;
    • Joeng, Hee-Koung;
    • Tipping, Robert W;
    • Du, Jiejun;
    • DePestel, Daryl D;
    • Butterton, Joan R;
    • Paschke, Amanda
    Publication type:
    Article
    25
    26
    27

    2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP).

    Published in:
    Open Forum Infectious Diseases, 2019, v. 6, p. S760, doi. 10.1093/ofid/ofz360.1904
    By:
    • Wunderink, Richard G;
    • Bruno, Christopher;
    • Martin-Loeches, Ignacio;
    • Kollef, Marin;
    • Timsit, Jean-Francois;
    • Yu, Brian;
    • Huntington, Jennifer A;
    • Li, Linping;
    • Jensen, Erin;
    • Wolf, Dominik;
    • Butterton, Joan R;
    • Rhee, Elizabeth G
    Publication type:
    Article
    28

    Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.

    Published in:
    2021
    By:
    • Timsit, Jean-François;
    • Huntington, Jennifer A.;
    • Wunderink, Richard G.;
    • Shime, Nobuaki;
    • Kollef, Marin H.;
    • Kivistik, Ülo;
    • Nováček, Martin;
    • Réa-Neto, Álvaro;
    • Martin-Loeches, Ignacio;
    • Yu, Brian;
    • Jensen, Erin H.;
    • Butterton, Joan R.;
    • Wolf, Dominik J.;
    • Rhee, Elizabeth G.;
    • Bruno, Christopher J.
    Publication type:
    journal article
    29
    30
    31

    Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy Adults.

    Published in:
    Clinical Drug Investigation, 2021, v. 41, n. 2, p. 133, doi. 10.1007/s40261-020-00974-8
    By:
    • Caro, Luzelena;
    • Prueksaritanont, Thomayant;
    • Fandozzi, Christine M.;
    • Feng, Hwa-Ping;
    • Guo, Zifang;
    • Wolford, Dennis;
    • Panebianco, Deborah;
    • Fraser, Iain P.;
    • Levine, Vanessa;
    • Swearingen, Dennis;
    • Butterton, Joan R.;
    • Iwamoto, Marian;
    • Yeh, Wendy W.
    Publication type:
    Article
    32
    33

    Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects.

    Published in:
    Journal of Clinical Pharmacology, 2018, v. 58, n. 7, p. 897, doi. 10.1002/jcph.1094
    By:
    • Marshall, William L.;
    • McCrea, Jacqueline B.;
    • Macha, Sreeraj;
    • Menzel, Karsten;
    • Liu, Fang;
    • van Schanke, Arne;
    • de Haes, Joanna I. Udo;
    • Hussaini, Azra;
    • Jordan, Heather R.;
    • Drexel, Melissa;
    • Kantesaria, Bhavna S.;
    • Tsai, Christine;
    • Cho, Carolyn R.;
    • Hulskotte, Ellen G. J.;
    • Butterton, Joan R.;
    • Iwamoto, Marian
    Publication type:
    Article
    34
    35
    36
    37
    38

    Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.

    Published in:
    2022
    By:
    • Martin-Loeches, Ignacio;
    • Timsit, Jean-François;
    • Kollef, Marin H.;
    • Wunderink, Richard G.;
    • Shime, Nobuaki;
    • Nováček, Martin;
    • Kivistik, Ülo;
    • Réa-Neto, Álvaro;
    • Bruno, Christopher J.;
    • Huntington, Jennifer A.;
    • Lin, Gina;
    • Jensen, Erin H.;
    • Motyl, Mary;
    • Yu, Brian;
    • Gates, Davis;
    • Butterton, Joan R.;
    • Rhee, Elizabeth G.
    Publication type:
    journal article
    39